JPRN-jRCTs042220163招募中2 期
Multicenter prospective study of safety and acceptance of capsule endoscopy examinations at home - HomeCam-J study
Ohmiya Review Naoki0 个研究点目标入组 30 人开始时间: 2023年3月24日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 < 65age old（—）
- 性别
- All
入选标准
- •Patients who have received sufficient explanation before participating in this study, and have
- •obtained written consent by their own free will
- •with sufficient understanding.
- •Patients aged between 18 and 65 at the time of
- •Colon capsule endoscopy: fecal immunochemical test-positive,screening for colorectal cancer,
- •ulcerative colitis
- •Small bowel capsule endoscopy: all small bowel
- •diseases or suspected disease without the
- •passage test by the patency capsule
排除标准
- •1.People who have previously undergone capsule endoscopy
- •2.Crohn's disease
- •3.After gastrointestinal surgery
- •4.After abdominal radiotherapy
- •5.Long-term use of nonsteroidal anti-inflammatory drug
- •6.Stenosis or suspected stenosis of the digestive
- •7.History of intestinal obstruction
- •8.Severe constipation
- •9.Active gastrointestinal bleeding
- •10.Cardiac hypertrophy
- •11.Systemic scleroderma
- •12. Patients in whom pacemaker or other medical devices are implanted
- •13. Dysplasia
- •14. Any other unsuitable conditions found by a
研究者
相似试验
招募中
不适用
Prospective multicenter study regarding the safety of surgical results of laparoscopic pancreatic resection; Japanese Society for Endoscopic Pancreatic Surgery, Japanese Society of Hepato-Biliary-Pancreatic Surgery, and Japan Society for Endoscopic Surgery cooperative studyPancreatobiliary diseases (Patients planned to undergo laparoscopic pancreatic resection)JPRN-UMIN000022836Japanese Society for Endoscopic Pancreatic Surgery3,000
进行中（未招募）
1 期
Safety and tolerability during open-label treatment with LCZ696 in patients with chronic heart failure and reduced ejection fractioHeart failure with reduced ejection fractionMedDRA version: 17.0Level: LLTClassification code 10019279Term: Heart failureSystem Organ Class: 100000004849EUCTR2014-001971-30-LVovartis Pharma services AG5,000
进行中（未招募）
1 期
Safety and tolerability during open-label treatment with LCZ696 in patients with chronic heart failure and reduced ejection fractioHeart failure with reduced ejection fractionMedDRA version: 17.1Level: LLTClassification code 10019279Term: Heart failureSystem Organ Class: 100000004849EUCTR2014-001971-30-ITovartis Farma SPA5,000
进行中（未招募）
1 期
Safety and tolerability during open-label treatment with LCZ696 in patients with chronic heart failure and reduced ejection fractioHeart failure with reduced ejection fractionMedDRA version: 18.1Level: LLTClassification code 10019279Term: Heart failureSystem Organ Class: 100000004849EUCTR2014-001971-30-DKovartis Pharma services AG5,000
进行中（未招募）
1 期
Safety and tolerability during open-label treatment with LCZ696 in patients with chronic heart failure and reduced ejection fractioHeart failure with reduced ejection fractionMedDRA version: 19.0Level: LLTClassification code 10019279Term: Heart failureSystem Organ Class: 100000004849EUCTR2014-001971-30-BGovartis Pharma services AG5,000